Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into ...

Yampolskiy categorizes self-improving software into three levels: self-modification, self-improvement, and recursive self-improvement. Self-modification primarily alters the appearance of code, while ...

Rallybio (RLYB) announced that it received an equity milestone payment of $12.5M from Recursion Pharmaceuticals (RXRX). The milestone payment was ...

Forbes contributors publish independent expert analyses and insights. I write about the business of healthcare. This article is more than 4 years old. Chris Gibson, Co-Founder & CEO, Recursion ...

Hamilton, Bermuda, September 11th, 2025, ChainwireOnRe, an onchain asset manager delivering institutional-grade yield to ...

Recursion Pharmaceuticals has significantly lagged the market since its 2021 IPO. The company's potentially revolutionary approach has yet to produce results. The stock's upside is enormous if ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the 10 Best Penny Stocks to Buy for the Next 5 Years. On August 5, Needham reiterated its Buy rating on Recursion Pharmaceuticals, Inc.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Self-Referential Large Models: Recursive Self-Enhancement in Code Generation ...

OnRe launched OnRe Points, a rewards program designed to incentivize meaningful participation in the ONyc ecosystem.

Autonomous AI agents are more than just extensions of vendor tools. They’re credentialed actors who connect and execute, and ...